According to the foreign media on April 24, one of the world’s largest medical technology & medical equipment company BD (Becton Dickinson) announced that it would acquire Bard (C R Bard) in a $24 billion cash-and-stock deal.

Such deal has obtained the approval of the board of directors of both companies. BD will pay USD 222.93 in cash and 0.5077 shares of BD stock per Bard share, or a total of value of USD 317.00 per item of stock based on BD's closing price of the last Friday.

According to the sales ranking of top 100 medical device companies, upon fusion of the No.9 BD and the No.24 Bard, the sales may exceed Roche, Phillips and Cardinal Health and rank the global top 5, only second to Medtronic, Johnson & Johnson, GE and Siemens.